See how dynamic chest X-rays relate to COPD patterns and progression risk
Official title: Dynamic Functional Imaging Phenotyping and Disease Progression Risk Assessment in COPD Using Dynamic Chest Radiography: A Multicenter Retrospective Study
Run by Nanfang Hospital, Southern Medical University · NCT07762573 · Data updated 2026-11-12
This study looks at existing dynamic chest radiography data to see if new imaging measurements can identify COPD patterns, gauge severity, and predict who may experience faster progression.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 30 Years to 85 Years |
| Sex | All |
| Enrollment | 2500 (estimated) |
| Sponsor | Nanfang Hospital, Southern Medical University Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | August 3, 2026 |
| Main results expected | December 30, 2029 |
| Study ends | January 30, 2030 |
| Registry record updated | August 13, 2026 |
| Trial ID | NCT07762573 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 30–85 with COPD who have undergone pulmonary function testing and dynamic chest radiography at participating centers.
✕Probably not a fit
Patients whose records are incomplete or who do not fit the imaging data criteria may not benefit from the findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter retrospective analysis collects prior dynamic chest radiography, lung function tests, CT images, symptom scores, and follow-up data to build a standardized database. The goal is to characterize dynamic functional imaging phenotypes in COPD and to explore tools for predicting disease progression. Findings will inform model development and set the stage for future prospective validation across centers.
Why it matters
Potential benefit: If successful, the study could provide imaging-based ways to better classify COPD and forecast progression, potentially guiding earlier or more tailored management.
How similar studies have gone: Previous work suggests imaging-based phenotyping can contribute to COPD characterization, but this approach with dynamic chest radiography is relatively novel and exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Aged 30-85 years. 2. Male or female. 3. Patients who underwent pulmonary function testing and dynamic chest radiography at the hospital. Exclusion Criteria: 1. Incomplete medical records. 2. Considered unsuitable for inclusion in the study at the investigator's discretion.
Where it's running
-
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China Recruiting
Study contacts
- Study coordinator: Laiyu Liu, Professor
- Email: liulaiyu@sina.com
- Phone: +86 13632102245
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Flutter therapy added to chest physiotherapy after CABG in COPD patients
This study tests whether adding Flutter therapy to standard chest physiotherapy helps post-CABG patients with mild-to-moderate COPD improve breathing more than chest physiotherapy alone.
-
TPB-based cadence exercise and breathing training for COPD patients
A TPB-based program tests whether breathing training, cadence-guided walking, or both can improve lung function, exercise capacity, and quality of life in adults with COPD.
-
Personalized mobile app warnings to reduce COPD flares
A personalized mobile app tests whether providing temperature-related risk warnings and protective tips, in addition to usual COPD care, can lower COPD flare-ups over 12 months.
-
CLEAR model to predict when people with severe COPD can be taken off ventilatory support
This project will see if the CLEAR model can predict which adults with severe COPD on invasive or non‑invasive ventilation can be safely taken off ventilatory support.
-
Long-term safety of Tozorakimab in COPD patients with prior exacerbations
This study tests two long-term dosing regimens of tozorakimab in people with COPD who have a history of flare-ups and who completed earlier studies.
-
SLC25A48 expression in COPD patients
This study tests whether the mitochondrial choline transporter SLC25A48 is more or less active in people with COPD compared to healthy individuals and whether its levels relate to inflammation and choline metabolism.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.